Search results for: Innovation Policy Prize
Filter search results
Seminar Briefing: The UK Biotech Sector and Brexit
1 May 2018
…Commentators and policymakers have expressed concern about the status of the biotech industry in the UK, as compared with the United States. In this Seminar Briefing, Owen and Hopkins outline…
How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper
18 July 2018
What would be the price for an orphan drug that generate rates of return no greater/smaller than the industry average? Is it reasonable? The high cost of drugs for rare…
Opportunity Costs of New Health Care Technologies: A Research Agenda
8 August 2018
A new OHE Research Paper sets out an agenda for the development of methods to estimate cost-effectiveness thresholds in the NHS. For many years, health economists have been concerned with…
New Publication: Advanced Therapy Medicinal Products and Health Technology Assessment
12 October 2018
A new publication in the European Journal of Health Economics identifies potential challenges of ATMPs in view of current health technology assessment (HTA) methodology and explores potential solutions to these…
OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?
16 January 2020
…and pricing patterns. Some empirical examples will be discussed to illustrate these points. Dr Alistair McGuire is Professor of the Department of Health Policy at London School of Economics. Prior to…
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
14 April 2020
…the reward-for-value equation, provide more consistent signals and thus the incentive to invest in more valuable innovations and in better healthcare. This study received unrestricted funding from the Pharmaceutical Research…
How Should the World Pay for a COVID-19 Vaccine?
31 July 2020
This year’s OHE lecture addressed the question: how should the world pay for a COVID-19 vaccine? The paper by Adrian Towse and Isobel Firth accompanying the lecture is now published….
The Value of Diagnostic information (VODI) in Heart Failure – Recognising Value Beyond ‘Beats-Per-Minute’
3 December 2020
…Heart Failure Policy Network, followed by presentations from Ms Sophie Marie Meiser, Manager of Market Access and Economic Policies at MedTech Europe, and Bernarda Zamora, Senior Economist at the Office…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
Histology independent therapies are changing the picture of cancer treatment and in so doing don’t ‘fit the frame’ of value assessment. What are the key challenges on the pathway from…